Protein from white lupin is capable of lowering plasma lipids. We investigated in this study the effect of total protein extracts (TPEs) from different cultivars of blue lupin (Probor, Vitabor and Boregine) and -/-conglutin from Boregine on the plasma lipids of rats. Rats were fed on a hypercholesterolemic diet containing either lupin protein (50 g/kg) or casein (50 g/kg) for 17 d. The rats fed with TPE from Vitabor and -/-conglutin had lower triglyceride concentrations in the plasma (À24% and À21%, respectively) and very-lowdensity lipoprotein (VLDL; À40% and À29%, respectively) than the rats fed with casein. TPE from Vitabor was also capable of lowering low-density lipoprotein (LDL) cholesterol (À37%). In the liver of the rats fed with TPE from Vitabor, the expression of the genes involved in triglyceride and cholesterol synthesis was down-regulated. This study shows that the Vitabor cultivar of blue lupin had the most beneficial effect on plasma lipids which was presumed to have been caused by the down-regulation of genes involved in lipid synthesis.
Dyslipidemia and its implication for atherogenesis and cardiovascular events is a major problem in human health. Legumes have been shown to lower the circulating concentrations of cholesterol [1] [2] [3] [4] and triglycerides 1, [5] [6] [7] in human and animal models when compared to casein. However, most of these studies were done with soybean protein or soy protein-associated antinutritive factors such as isoflavones.
Another protein-rich legume besides soy is lupin. The sweet varieties of lupin have long been cultivated for domestic animal feed and also for human nutrition, mainly in several parts of Australia, Europe and South America. Nowadays, four Mediterranean species of lupin (Lupinus albus L., L. angustifolius L., L. luteus L. and L. mutabilis L.) are cultivated for nutrition and they are referred to as sweet lupins since they each contain a smaller amount of toxic alkaloids than the bitter varieties. Their use by the food industry is being developed, and lupin protein is beginning to replace soybean protein in several food products. 8) Recent studies have shown that a protein extract from white lupin was also capable of lowering plasma lipids in laboratory animals. 4, 6, 7) The protein and amino acid contents of lupin seed and soya are very similar, but the amount of isoflavones and other antinutritive factors is minimal in lupin. 4, 6, 9, 10) Due to its high protein content, N fixation, tap-root formation and environmental robustness, blue lupin (L. angustifolius L.) also offers interesting perspectives for food and feed usage, plant cultivation, and agroecology. Different breeds of blue lupin are currently cultivated, and their proteins have also been found to be valuable for human nutrition. A recent study has shown that pigs fed on a diet with a blue lupin seed had a lower low-density lipoprotein (LDL) cholesterol concentration than pigs fed on casein.
11)
However, it is not currently known whether an isolated protein extract from blue lupin may also possess hypolipemic properties. The present study was aimed to investigate the effects of total protein extracts (TPEs) from different cultivars of blue lupin (Probor, Vitabor and Boregine) on the concentrations of lipids in the plasma, lipoproteins and liver of rats which were used as an animal model. In most rat studies dealing with the effects of plant proteins on lipid metabolism, the test protein has been added to the diet in a large amount up * The research was supported by a grant from the Bundesministerium für Wirtschaft und Technologie (BMWi). y To whom correspondence should be addressed. Fax: +49-345-5527124; E-mail: gabriele.stangl@landw.uni-halle.de Abbreviations: ABC, ATP-binding cassette transporter; apo, apolipoprotein; CYP7A1, cholesterol 7-hydroxylase; FAS, fatty acid synthase; FXR, farnesoid X receptor; HDL, high-density lipoprotein; HL, hepatic lipase; HMG-CoA, 3-hydroxy-3-methylglutaryl coenzyme A; LDL, low-density lipoprotein; LPL, lipoprotein lipase; SCD, stearoyl-CoA desaturase; SREBP, sterol regulatory element-binding protein; TPE, total protein extract; VLDL, very-low-density lipoprotein to 25% as an exclusive protein source. 5, 12, 13) However, such a large amount of lupin protein is unrealistic for practical nutrition, so we decided to add the dietary test protein in an amount of 5%.
A few data have indicated that such specific polypeptides from legumes as -conglycinin from soy 14, 15) and conglutin from white lupin 4) contributed to the hypolipemic effect. To test the hypolipemic potential of -and -conglutins one group of animals was fed with an -/-conglutin-containing protein extract from TPE of the Boregine cultivar.
Recent data have indicated that the hypolipemic effect of lupin protein was probably caused by the altered activity of the hepatic transcription factors involved in lipid metabolism such as sterol regulatory elementbinding protein (SREBP). 6, 7) SREBPs are transcription factors which directly activate the expression of more than 30 genes dedicated to the regulation of lipid levels. 16) While SREBP-2 is primarily responsible for the regulation of genes involved in cholesterol biosynthesis and uptake, 17, 18) SREBP-1c is involved in the regulation of genes involved in fatty acid biosynthesis. 19) In this study, we wanted to test whether an altered lipid concentration in the plasma or liver of rats was associated with the altered transcription levels of SREBPs and their target genes.
However, there are also other genes not depending on SREBP activation which could be responsible for a protein-induced alteration of triglyceride and cholesterol metabolism. We therefore also measured those genes that play a critical role in the hydrolysis of circulating triglycerides such as hepatic lipase (HL) and apoA5. 20, 21) The hepatic gene expression of cholesterol 7-hydroxylase (CYP7A1), farnesoid X receptor (FXR) and ATP-binding cassette transporter (ABC)-G5, which are involved in the synthesis of bile acids from cholesterol and the transfer of cholesterol into the bile, may also help to elaborate the possible mechanism by which lupin protein can influence cholesterol metabolism.
Materials and Methods
Animals and experimental diets. Sixty 4-wk-old male Sprague-Dawley rats (Charles River, Sulzfeld, Germany) with an initial body weight of 85.3 g (AE12:2; SD) were randomly assigned to five groups of 12 rats each. All the rats were kept individually in Macrolon cages in a room maintained at 22 AE 2 C and 50-60% relative humidity with lighting from 06.00 to 18.00 h. All the experimental procedures described followed established guidelines for the care and use of laboratory animals and were approved by the council of SaxonyAnhalt, Germany.
All the rats were fed on a semi-synthetic diet containing 200 g/kg of protein which consisted of 150 g/kg of egg albumin in order to meet the amino acid requirements of the rats and 50 g/kg of the test protein. To induce hypercholesterolemia, the diet was supplemented with 10 g/kg of cholesterol and 5 g/kg of sodium cholate. The four experimental groups each received 50 g/kg of a total protein extract from either the Boregine, Probor or Vitabor cultivar of L. angustifolius L., and -/-conglutin from the Boregine cultivar, respectively. The group fed with 50 g/kg of casein served as the control group. The composition of the semi-synthetic diets is shown in Table 1 . Vitamins and minerals were supplemented according to the recommendations of the American Institute of Nutrition for rat diets. 22) In order to standardize the food intake, each diet was fed daily in an amount of 9 g per day. Nipple drinkers provided free access to water. The experimental diets were fed for 17 d.
Preparation and characterization of the dietary proteins. Casein was obtained from Meggle (Wasserburg, Germany) and was not further processed. The lupin protein isolates were obtained from the Fraunhofer Institute (IVV, Freising, Germany). Lupin proteins were extracted from deoiled lupin; the -/-conglutincontaining protein fraction of the Boregine cultivar was also obtained from the Fraunhofer Institute, and was separated by using the alkaline extraction and acid precipitation procedures described elsewhere.
23) The crude components of the dietary proteins were determined by the official methods of Verband Deutscher Landwirtschaftlicher Untersuchungs-und Forschungsanstalten 24) and are shown in Table 2 . The concentrations of the isoflavones, genistein, daidzein and genistin, in the lupin protein were analyzed by an HPLC method. 25) In brief, lupin protein To analyze the amino acid concentrations in the diet, samples were oxidized and then hydrolysed with 6 M HCl. 26) Separation and quantification of the amino acids were performed by ion-exchange chromatography after post-column conversion in an amino acid analyzer (Biotronic LC 3000, Eppendorf, Hamburg, Germany). 27) Tryptophan was determined by digesting the diet with barium hydroxide.
28) The dietary tryptophan concentration was detected by reversed-phase high-performance liquid chromatography.
29) The concentrations of amino acids in the diets are shown in Table 3 .
Sample collection. The rats were killed by decapitation under light anaesthesia with diethyl ether. Each rat received 4 g of the diet 4 h before decapitation, because short-term starvation significantly down-regulated the transcription levels of genes encoding the enzymes of lipid metabolism 19) which were to be measured in this study. Whole blood was collected in heparinized polyethylene tubes, and the plasma was separated by centrifugation at 1;500 Â g for 10 min at 4 C. The liver was excised, weighed and immediately snap frozen in liquid nitrogen. Aliquots of the liver for RNA isolation were stored at À80 C, and plasma was stored at À20 C.
Plasma and liver lipids. Very-low-density lipoproteins (VLDL), LDL and high-density lipoproteins (HDL) were separated by step-wise ultracentrifugation (900;000 Â g at 4 C for 1.5 h; Mikro-Ultrazentrifuge, Sorvall Products, Bad Homburg, Germany) by appropriate density cuts (VLDL, p < 1:006 kg/l; LDL, 1:006 kg/l < p < 1:063 kg/l; HDL, p > 1:063 kg/l). The plasma density was adjusted by sodium chloride and potassium bromide. Lipids from the liver were extracted with a mixture of n-hexane and isopropanol (3:2, v/v).
30) The concentrations of lipids in the liver were determined with an enzymatic reagent kit, after drying an aliquot of the lipid extract and dissolving the lipids with Triton-X.
31) The concentrations of cholesterol and triglycerides in the plasma and lipoproteins and those in the liver were examined with enzymatic reagent kits (DiaSys Diagnostic Systems, Holzheim, Germany, Cat-nos. 1.1300 99 90 314 and 1.5760 99 90 314).
RNA isolation and real-time RT-PCR.
To determine the mRNA expression levels of SREBP-1c, fatty acid synthase (FAS, EC 2.3.1.85), stearoyl-CoA desaturase-1 (SCD1, EC 1.14.99.5), HL (EC 3.1.1.3), apoA5, SREBP-2, 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase (EC 1.1.1.34), LDL-receptor, FXR, CYP7A1 (EC 1.14.13.17) and ABC-G5 in the liver, total RNA was isolated by using the TRIZOLÔ reagent (Invitrogen, Karlsruhe, Germany) according to the manufacturer's instructions. The RNA concentration and purity were estimated from the optical density at 260 and 280 nm, respectively. Total RNA (1.2 mg) was subjected to first-strand cDNA synthesis at 42 C for 60 min, using M-MuLV reverse transcriptase (MBI Fermentas, St. Leon-Rot, Germany) and the oligo dT18-primer (Operon Biotechnologies, Cologne, Germany). The mRNA concentrations of genes were measured by real-time PCR with the rotorgene 2000 system (Corbett Research, Mortlake, Australia). Realtime detection was performed by using SYBR Ò Green I (Sigma, Taufkirchen, Germany), 1.25 U Taq DNA polymerase (Promega, Mannheim, Germany), 500 mM dNTPs and 26.7 pmol of the specific primers (Operon Biotechnologies). The sequences and annealing temperatures of SREBP-1c, FAS, SCD1, HL, apoA5, SREBP-2, HMG-CoA reductase, LDL-receptor, FXR and CYP7A1 have been described elsewhere.
6) The primer sequences for PCR analyses of ABC-G5 were 5 0 -ATGGCCTGTACCAGAAGTGG-3 0 (forward) and 5 0 -AGCGGCAGAGAAGTATCCAA-3 0 (reverse), and of -actin were 5 0 -ATCGTGCGTGACATTAAAGAGAAG-3 0 (forward) and 5 0 -GGACAGTGAGGCCAGGATA-GAG-3 0 (reverse). Each PCR cycle comprised denatura- tion for 20 s at 95 C, annealing for 30 s at a primerspecific temperature (58-65 C) and elongation at 72 C for 55 s. The intensity of fluorescence in all probes was measured at the end of the elongation step. To determine the mRNA concentration, the threshold cycle (C t ) and amplification efficiency were obtained from each amplification curve by using RotorGene 4.6 software (Corbett Research). A melting curve analysis was then performed for identification of the products. The amplification of a PCR product was verified by using 1% agarose gel electrophoresis. The relative quantitation of target gene mRNA was compared to house-keeping gene -actin.
Statistics. Data were treated by an one-way analysis of variance, using MINITAB software (Minitab, State College, PA, USA). For statistically significant F values (P < 0:05), the means of the five groups were compared by Fisher's multiple-range test. Means were considered significantly different at P < 0:05.
Results

Body and liver weights
The initial and final body weights of the rats were similar in all groups ( Table 4 ). The liver weight of the rats fed with TPE from the Boregine cultivar was lower than that of the rats fed with casein, whereas the rats fed with -/-conglutin from the Boregine cultivar had a higher liver weight than the control rats fed with casein. The liver weight of the rats fed with TPE of Probor and Vitabor was no different from that of the control rats fed with casein (Table 4) .
Concentrations of triglycerides and cholesterol in the plasma, lipoproteins and liver
The rats fed with TPE from the Vitabor cultivar and -/-conglutin from the Boregine cultivar had lower concentrations of triglycerides in the plasma and in VLDL than the rats fed with casein (P < 0:05, Table 4 ). The triglyceride concentrations in the plasma and VLDL from the other groups were no different from those of the control group fed with casein. The triglyceride concentration in LDL and HDL were not influenced by the dietary protein (data not shown). The triglyceride concentration in the liver did not differ between the groups fed with lupin protein or casein ( Table 4) .
The cholesterol concentrations in the plasma, VLDL and HDL were no different between the rats fed with the lupin proteins and the rats fed with casein ( Table 4) . The group fed with the TPE from the Vitabor cultivar had a lower concentration of LDL cholesterol than the control group (À37%, P < 0:05). The LDL cholesterol concentration of the other groups fed with the lupin protein was no different from that of the control rats fed with casein ( Table 4 ). The cholesterol concentration in the liver was lower in the rats fed with TPE from the Boregine cultivar than in the rats fed with casein (P < 0:05). The cholesterol concentration in the liver of the rats fed with the other lupin proteins was no different from that of the rats fed with the casein diet (Table 4) .
Hepatic mRNA concentrations of the genes involved in triglyceride metabolism
The rats fed with TPE from the Vitabor cultivar had lower mRNA concentrations of SREBP-1 and FAS than the rats fed with casein (P < 0:05, Fig. 1 ). The mRNA concentration of SCD1 tended to be lower in the Vitabor group than in the control group fed with casein (P ¼ 0:057). The rats fed with -/-conglutin from the Boregine cultivar tended to have a lower hepatic mRNA concentration of FAS than the rats fed with casein (P ¼ 0:138), whereas the mRNA concentrations of SREBP-1c and SCD1 were no different from those of the control group (Fig. 1) . The mRNA concentrations of SREBP-1c, FAS and SCD1 in the liver of the rats fed with TPE from Probor and Boregine did not differ from those of the control rats (Fig. 1) . The hepatic mRNA abundance of apoA5 and HL involved in triglyceride hydrolysis was no different between the different groups of rats (Table 5) .
Hepatic mRNA concentrations of the genes involved in cholesterol and bile acid metabolism
The rats fed with the diet containing TPE from Vitabor had a lower hepatic mRNA concentration of HMG-CoA reductase than the rats fed with casein (P < 0:05, Fig. 2 ). The rats fed with TPE from Vitabor had a 37% lower mRNA concentration of SREBP-2 in the liver, although the difference was not statistically significant due to the high standard deviation (P ¼ 0:110, Fig. 2 ). The mRNA abundance of the LDL receptor tended to be lower in the rats fed with the TPE from Vitabor than in the rats fed with casein (À43%, P ¼ 0:069, Fig. 2 ). The hepatic mRNA concentrations of SREBP-2, HMG-CoA reductase and LDL receptor in the rats fed with TPE from Probor, Boregine and -/-conglutin from the Boregine cultivar were no different from those of the control rats (Fig. 2) .
The rats fed with TPE from Vitabor had lower hepatic mRNA concentrations of CYP7A1, FXR and ABC-G5 than the rats fed with casein (P < 0:05, Table 5 ). No difference in the mRNA expression of these genes was apparent between the groups fed with TPE from Probor, Boregine or -/-conglutin from Boregine and the casein group (Table 5) .
Discussion
The results from this study demonstrate that isolated proteins from different cultivars of blue lupin exerted different effects on the lipid concentrations in the plasma, lipoproteins and liver. The most beneficial effects on circulating triglycerides were exerted by TPE from Vitabor and -/-conglutin from the Boregine cultivar which were capable of lowering VLDL triglycerides by 40% and 29%, respectively, compared to casein. These two protein isolates also notably lowered the mRNA concentrations of SREBP-1c, FAS and SCD1 by 27-78%, although the data obtained with -/-conglutin from Boregine did not reach the level of significance. The ability of these two proteins to downregulate the mRNA levels of these genes involved in triglyceride synthesis provides a plausible mechanism for the triglyceride-lowering effect and agrees with the results from recent studies in which hyper-and normocholesterolemic rats that received isolated proteins from white lupin compared to casein had lower concentrations of circulating triglycerides and also lower mRNA concentrations of the genes involved in triglyceride synthesis.
6,7) Although we are aware that expression data do not necessarily reflect a protein or activity level, it is a fact that the gene expression of SREBP-1c is the key regulatory step for its activity and ultimately determines hepatic lipogenesis. 32, 33) However, in contrast to the results in recent studies in which the proteins from white lupin could also lower the triglyceride concentration in the liver, 6,7) the hepatic triglyceride concentration in the rats fed with TPE from Vitabor and -/-conglutin from the Boregine cultivar was not significantly different from that of the control rats. The reason for the insignificant effect of lupin protein on hepatic triglyceride in this study is not yet clear, but we assume that the down-regulation of triglyceride synthesis was much stronger under the experimental conditions used in the recent studies with white lupin protein. 6, 7) In one of the studies using protein from white lupin, 7) rats were fed 200 g of lupin protein per kg of diet instead of the 50 g/kg used in this study, and the concentration of VLDL triglycerides was reduced by 81%, instead of the 30% and 40% observed in this study using TPE from Vitabor and -/-conglutin from Boregine. In another lupin protein study, VLDL triglycerides were lowered by 52%. 6) We thus assume that the reduction of triglyceride synthesis in this study by using cultivars from blue lupin was not strong enough to significantly reduce the triglyceride content in the liver within the 17 d of the experiment.
We further found that the mRNA concentrations of apoA5 and HL were not altered in the rats fed with TPE from the Vitabor cultivar or from any other lupin protein isolate compared to the rats fed with casein. Both genes are involved in VLDL catabolism, and a recent study had shown that protein from white lupin was capable of up-regulating the mRNA concentrations of both genes compared to casein. 6) While HL functions as a lipolytic enzyme that hydrolyses triglycerides in circulating plasma lipoproteins and also serves as a ligand facilitating lipoprotein uptake by cell surface receptors, 20) apoA5 is a newly identified apolipoprotein which has been found to accelerate VLDL catabolism by activating intravascular triglyceride hydrolysis via an enhancement of the binding between lipoproteins and proteoglycans at the vascular wall, activation of proteoglycan-bound lipoprotein lipase and VLDL removal from the plasma. 21) Based on our findings, we suggest that the observed triglyceride-lowering effect of TPE from Vitabor and of -/-conglutin from the Boregine cultivar was mainly caused by an inhibition of triglyceride synthesis and not by any stimulation of triglyceride hydrolysis. This supports our hypothesis that the proteins from different species and cultivars of lupin would not exert identical effects on the lipid metabolism of laboratory animals.
However, not only triglycerides but also cholesterol metabolism was differently affected by the proteins from the cultivars of blue lupin. While the proteins from the Probor and Boregine cultivars did not influence the cholesterol concentration in the plasma and lipoproteins, TPE from Vitabor lowered the concentration of LDL cholesterol by 37% compared to casein. This finding agrees with the recently observed hypocholesterolemic effects of white lupin protein. 4, 6) Sirtori et al. 4) have suggested that the protein from white lupin was capable of stimulating the LDL receptor activity which in turn enhanced the uptake of circulating LDL from plasma into cells. However, in this study, the expression of LDL receptor mRNA tended to be lower in the liver of rats fed with TPE from Vitabor than in the rats fed with casein. It therefore seems unlikely that an increased uptake of cholesterol into the cells was responsible for the observed LDL cholesterol-lowering effect of TPE from Vitabor. We assume that the distinct down-regulation of the mRNA abundance of HMG-CoA reductase by 76% could have been responsible for the LDL cholesterollowering effect of TPE from Vitabor when compared with casein. It is known that the synthesis of cholesterol is mainly controlled at the level of transcription of HMGCoA reductase. 34) HMG-CoA reductase is the key enzyme for cholesterol synthesis and is regulated through the action of SREBP-2 binding to DNA elements in the gene promoter of HMG-CoA reductase. 35) It is known that HMG-CoA reductase inhibitors or statins used as cholesterol-lowering drugs effectively reduce the concentration of LDL cholesterol but not of HDL cholesterol. 35, 36) It therefore seems plausible that the observed reduction in LDL cholesterol could have been caused by down-regulation of the key enzyme for cholesterol synthesis. Dose-response studies should be performed to investigate whether a larger amount of lupin protein of up to 20% in the diet would exert a stronger effect on LDL cholesterol than the 5% level used here.
We also found in this study that the expression of genes involved in bile acid synthesis and the transfer of endogenous cholesterol into bile was lower in rats fed with TPE from Vitabor than in rats fed with casein. The genes which were down-regulated by TPE from Vitabor were CYP7A1, an initial and rate-limiting enzyme in the conversion of cholesterol to 7-hydroxylated bile acids, 37) FXR, which has been reported to modify the expression of bile acid transporters in the liver, 38) and ABC-G5 which is known to be involved in the transfer of cholesterol into bile. 39) It is known that the bile acid concentration is controlled by a feed-back regulatory pathway, whereby the activation of FXR represses the transcription of CYP7A1. 40) However, in this study, we found that lupin protein from Vitabor lowered both the FXR and CYP71A mRNA expression. To explain the mechanism whereby lupin protein may lower the mRNA concentrations of FXR and CYP7A1, further studies are required which will investigate the FXR expression in both the liver and intestines, because recent data have shown that the FXR-mediated repression of bile acid synthesis required the complementary action of FXR in both the liver and intestines.
41) It could be expected that the observed down-regulation of CYP7A1 and ABC-G5 in the liver of rats fed with lupin protein from Vitabor would result in a higher cholesterol concentration in the liver. However, the cholesterol concentration in the liver was not altered in comparison with the rats fed with casein. We assume that concurrently reduced cholesterol synthesis was responsible for the cholesterol concentration in the liver not being increased, despite the reduced CYP7A1 and ABC-G5 abundance.
Another finding was that the rats fed with TPE from Boregine had a lower cholesterol concentration in the liver than those fed with casein, although the concentrations of cholesterol in the plasma and lipoproteins were not altered. This effect cannot be explained by the altered transcription levels of those genes involved in cholesterol synthesis, cholesterol uptake into cells and bile acid synthesis, because neither the mRNA expression of SREBP-2 target genes nor the mRNA level of CYP7A1 was significantly altered in this group compared with the control group. We assume that this single effect is not associated with either beneficial or adverse effect on health.
In the search for nutrient factors responsible for the effects on triglyceride and cholesterol metabolism, different protein-associated factors such as isoflavones and amino acids have been discussed. We assume that isoflavones could not have been responsible for the hypolipemic effect, because their amounts were extremely low in the lupin protein isolates used in this study. We further assume that the different effects of the lupin proteins on the plasma lipid concentration were not caused by their amino acids, because all the lupin protein diets had a similar amino acid composition. We therefore suggest that the hypolipemic effect of TPE from Vitabor and of -/-conglutin from Boregine must have been induced by other nutrients associated with the protein. These factors remain to be identified. Specific tripeptides hydrolysed from dietary polypeptides in the intestine or bioactive phytochemicals other than isoflavones could have played a role in this effect. Further studies are necessary to identify the hypolipemic nutrients in the lipid-lowering lupin proteins.
In conclusion, this study has shown that the protein from the Vitabor cultivar of blue lupin had the most beneficial effect on VLDL triglycerides and LDL cholesterol, this being followed by -/-conglutin from the Boregine cultivar. The triglyceride-and LDL cholesterol-lowering effects of Vitabor TPE seem to have been the result of reduced expression of the genes involved in triglyceride and cholesterol synthesis. The different effects of the diverse cultivars and proteins from blue lupin seem not to have been caused by isoflavones and their amino acid composition.
